2025-01-16 21:18:10
Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037
Corporate/ 2023-07-24
Antengene Announces HREC Approval in Aus...

SHANGHAI and HONG KONG,Feb. 7,2022-- Antengene Corporation Limited ("Antengene",SEHK: 6996.HK),a leading innovative commercial sta...

Novavax Submits Request to the U.S. FDA for Emergency Use Authorization of COVID-19 Vaccine
Corporate/ 2023-07-24
Novavax Submits Request to the U.S. FDA ...

- NVX-CoV2373 demonstrated overall efficacy of ~90% in PREVENT-19 clinical trial conducted during the emergence of variant strains

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release